Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial ; volume:10 ; number:1 ; day:6 ; month:9 ; year:2010 ; pages:1-9 ; date:12.2010
BMC cancer ; 10, Heft 1 (6.9.2010), 1-9, 12.2010
- Urheber
- Beteiligte Personen und Organisationen
-
Kieser, Meinhard
Rieken, Stefan
Habermehl, Daniel
Jäkel, Oliver
Haberer, Thomas
Nikoghosyan, Anna
Haselmann, Renate
Unterberg, Andreas
Wick, Wolfgang
Debus, Jürgen
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-10-478
- URN
-
urn:nbn:de:1111-2016030359653
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Ähnliche Objekte (12)
Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume
Salvage laryngectomy after primary radio- and radiochemotherapy
Salvage radiotherapy in patients with local recurrent esophageal cancer after radical radiochemotherapy
Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging
Longitudinal atherosclerotic changes after radio(chemo)therapy of hypopharyngeal carcinoma
Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study
Radiochemotherapy in esophageal cancer
Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume
Salvage laryngectomy after primary radio- and radiochemotherapy
Salvage radiotherapy in patients with local recurrent esophageal cancer after radical radiochemotherapy
Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging
Longitudinal atherosclerotic changes after radio(chemo)therapy of hypopharyngeal carcinoma
Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study
Radiochemotherapy in esophageal cancer
Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume
Salvage laryngectomy after primary radio- and radiochemotherapy
Salvage radiotherapy in patients with local recurrent esophageal cancer after radical radiochemotherapy
Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging
Longitudinal atherosclerotic changes after radio(chemo)therapy of hypopharyngeal carcinoma
Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study